Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedOct 01, 2025
DataAggregated Company Financials
Companies66
  • 7D2.9%
  • 3M10.9%
  • 1Y-3.3%
  • YTD5.0%

The Biotech is pretty flat in the last 7 days, but PharmaEssentia has stood out, gaining 7.7%. Unfortunately though, the industry is down 6.2% over the past 12 months. As for the next few years, earnings are expected to grow by 52% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Oct 2025NT$553.4bNT$32.2b-NT$8,364,979,000.0039.8x-66.2x17.2x
Sat, 30 Aug 2025NT$525.0bNT$32.2b-NT$8,215,909,000.0033.7x-63.9x16.3x
Mon, 28 Jul 2025NT$504.3bNT$31.3b-NT$6,301,777,000.0031.3x-80x16.1x
Wed, 25 Jun 2025NT$512.3bNT$30.2b-NT$6,460,452,000.0037.8x-79.3x16.9x
Fri, 23 May 2025NT$490.2bNT$30.0b-NT$6,443,317,000.0031.3x-76.1x16.3x
Sun, 20 Apr 2025NT$470.0bNT$28.3b-NT$7,180,905,000.0031x-65.4x16.6x
Tue, 18 Mar 2025NT$531.4bNT$28.1b-NT$8,214,097,000.0032.9x-64.7x18.9x
Thu, 13 Feb 2025NT$598.1bNT$24.8b-NT$10,902,841,000.0038.1x-54.9x24.1x
Sat, 11 Jan 2025NT$562.3bNT$24.8b-NT$10,902,841,000.0034.9x-51.6x22.7x
Mon, 09 Dec 2024NT$514.8bNT$24.8b-NT$10,848,531,000.0037.2x-47.5x20.8x
Wed, 06 Nov 2024NT$548.6bNT$23.5b-NT$10,829,095,000.0042.5x-50.7x23.4x
Fri, 04 Oct 2024NT$551.8bNT$23.5b-NT$10,829,095,000.0036x-51x23.5x
Sun, 01 Sep 2024NT$583.8bNT$23.5b-NT$10,883,302,000.0035.1x-53.6x24.9x
Tue, 30 Jul 2024NT$549.0bNT$21.9b-NT$11,053,865,000.0042.1x-49.7x25x
Thu, 27 Jun 2024NT$520.7bNT$21.9b-NT$11,110,643,000.0043.2x-46.9x23.7x
Sat, 25 May 2024NT$489.1bNT$21.9b-NT$11,084,581,000.0042x-44.1x22.3x
Mon, 22 Apr 2024NT$429.2bNT$21.1b-NT$12,242,614,000.0046.6x-35.1x20.3x
Wed, 20 Mar 2024NT$433.4bNT$21.0b-NT$10,159,738,000.0044.5x-42.7x20.6x
Fri, 16 Feb 2024NT$438.6bNT$19.9b-NT$9,857,794,000.0040.4x-44.5x22x
Sun, 14 Jan 2024NT$458.8bNT$19.8b-NT$9,748,146,000.0038.9x-47.1x23.2x
Tue, 12 Dec 2023NT$472.7bNT$19.9b-NT$9,737,975,000.0043x-48.5x23.8x
Thu, 09 Nov 2023NT$486.4bNT$18.5b-NT$10,820,022,000.0050.3x-45x26.2x
Sat, 07 Oct 2023NT$472.2bNT$18.3b-NT$10,774,226,000.0045.1x-43.8x25.8x
Mon, 04 Sep 2023NT$493.2bNT$18.3b-NT$10,596,353,000.0043.3x-46.5x26.9x
Wed, 02 Aug 2023NT$475.6bNT$18.6b-NT$10,793,316,000.0051.4x-44.1x25.6x
Fri, 30 Jun 2023NT$493.3bNT$18.7b-NT$10,709,428,000.0044.4x-46.1x26.4x
Sun, 28 May 2023NT$490.6bNT$19.0b-NT$9,947,560,000.0044.2x-49.3x25.9x
Tue, 25 Apr 2023NT$516.4bNT$18.4b-NT$9,803,110,000.0040.8x-52.7x28x
Thu, 23 Mar 2023NT$494.6bNT$22.5b-NT$7,261,002,000.0037.1x-68.1x22x
Sat, 18 Feb 2023NT$521.9bNT$21.8b-NT$7,832,470,000.0038x-66.6x23.9x
Mon, 16 Jan 2023NT$487.4bNT$21.8b-NT$7,778,690,000.0035.9x-62.7x22.4x
Wed, 14 Dec 2022NT$518.7bNT$21.8b-NT$7,522,211,000.0037.6x-69x23.8x
Fri, 11 Nov 2022NT$479.5bNT$23.1b-NT$6,619,282,000.0036.2x-72.4x20.8x
Sun, 09 Oct 2022NT$511.1bNT$23.1b-NT$6,633,590,000.0038.2x-77.1x22.1x
Price to Earnings Ratio

-77.1x


Total Market Cap: NT$511.1bTotal Earnings: -NT$6,633,590,000.00Total Revenue: NT$23.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -55x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 22.3x is higher than the industry's current PS ratio of 17.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-0.85%
Healthcare1.66%
Biotech2.89%
Biotech2.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$552.006.4%
+NT$12.2b		-4.7%PE50.4x
6712 Ever Supreme Bio TechnologyNT$187.006.3%
+NT$963.6m		10.6%PE40.2x
6875 Pharmosa BiopharmNT$49.507.1%
+NT$426.0m		-23.5%PS36.8x
6610 TWi BiotechnologyNT$36.4511.0%
+NT$387.5m		171.0%PB14.6x
4174 OBI PharmaNT$27.355.4%
+NT$368.2m		-66.0%PS116.5x

Latest News

6973
NT$47.85
U-Neuron Biomedical
7D
17.6%
1Y
19.5%
6610
NT$36.45
TWi Biotechnology
7D
11.0%
1Y
171.0%
6550
NT$36.05
Polaris Group
7D
-3.1%
1Y
-34.3%
4174
NT$27.35
OBI Pharma
7D
5.4%
1Y
-66.0%
1783
NT$47.85
Maxigen Biotech
7D
5.2%
1Y
12.5%
1295
NT$117.50
Synbio Tech
7D
-4.1%
1Y
30.7%
6712
NT$187.00
Ever Supreme Bio Technology
7D
6.3%
1Y
10.6%
6547
NT$38.25
Medigen Vaccine Biologics
7D
-2.4%
1Y
-15.1%
4728
NT$407.50
Sunmax Biotechnology
7D
-1.7%
1Y
51.5%
4147
NT$76.70
TaiMed Biologics
7D
-0.9%
1Y
-3.4%
6446
NT$552.00
PharmaEssentia
7D
6.4%
1Y
-4.7%
6794
NT$81.20
UnicoCell Biomed
7D
-9.9%
1Y
4.5%
6875
NT$49.50
Pharmosa Biopharm
7D
7.1%
1Y
-23.5%
6696
NT$164.50
Lin BioScience
7D
2.5%
1Y
76.7%
7762
NT$84.40
Pet Pharm Biotech
7D
-3.7%
1Y
127.8%